Navigation Links
Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock
Date:10/12/2010

COLORADO SPRINGS, Colo., Oct. 12 /PRNewswire/ -- Cannabis Science, Inc. (OTC Bulletin Board: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce guidance on its product development and FDA Investigative New Drug Applications for its cannabis clinical trials. The Company is also pleased to announce the proposed dividend payout to current shareholders for a new class of common shares is under review by counsel, and the Company expects to announce the date of shareholder record, the proposed share ratio payments, and attached financing options within the next few days.

Cannabis Science Inc. President & CEO, Dr. Robert Melamede Ph.D., commented, "We are at the beginning stages of our growth curve right now. This is the most exciting time yet for us all in our short history, we see the proposed dividend payout with the proposed new class of common shares as a way to multiply, reward, and increase our investor options and participation. Our operational structure has been increased dramatically by the ever-increasing amount of partnership opportunities. We have seen some impressive results worldwide from cannabis patients, whether they are using medical cannabis in what is considered informal trials or for personal edification. Absurdly, this vast trove of clinical experience has been dismissed as 'anecdotal.' At some point that willful blindness is not only unscientific, it is simply dishonest. However, it has created a great opportunity for us. Cannabis Science is in the strategic planning phase with respect to the enormous amount of positive research and data collection coming from all of this 'real world' experience of thousands of Colorado patients. Consequently, we are forming a well-qualified team of physicians, and this data will be compounded through our RockBrook agreements and later used with respect to the FDA ap
'/>"/>

SOURCE Cannabis Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill
2. DC Patients Cooperative Urges Changes to the Proposed Medical Cannabis Marijuana Regulations
3. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... India , September 4, 2015 ... 2015 Market Research Report is a professional and ... global Surgical Gown industry with a focus on ... take 2-3 working days once an order is ... market spread across 150 pages, analyzing and profiling ...
(Date:9/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... in the upcoming Rodman & Renshaw 17 th ... in New York City .  Dr. ... a corporate overview on September 9, 2015. ...
(Date:9/4/2015)... DUBLIN , Sep. 04, 2015 ... ) has announced the addition of the ... - December 7-8, 2015)" conference to their ... take participants through all of the constituent parts ... veterinary medicinal product for which a marketing authorisation ...
Breaking Medicine Technology:Surgical Gown Market 2020 Forecasts With a Focus on China 2Surgical Gown Market 2020 Forecasts With a Focus on China 3Surgical Gown Market 2020 Forecasts With a Focus on China 4Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2
(Date:9/4/2015)... (PRWEB) , ... September 05, 2015 , ... Paradise ... from China for an exclusive, one-night exhibition of their work at Paradise Valley Community ... on Friday, September 18, from 6-9 pm. The artists will be on hand to ...
(Date:9/4/2015)... Chicago, IL (PRWEB) , ... September 04, 2015 ... ... 2013 and 2014, Insight Product Development has effectively doubled the size of its ... early stage Midwest medical device and digital health startups to compete for cash ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The Providence ... to learn more about their fertility and egg freezing. , Date and Time: October ... 6PM to 7PM , This hip and informative event will discuss the basics of ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary ... waste handling rules constantly evolving in the consumer goods industry, it can be ...
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2
... getting through the backlog to help claimants with the process ... ... increase in people applying for Social Security disability benefits in 2008 ... according to Allsup , which represents tens of thousands of ...
... and Future Growth Opportunities in Transplant Diagnostics and Genetic ... 30 Gen-Probe Incorporated (Nasdaq: GPRO ), ... human disease, announced today that it has offered to ... Life Sciences, PLC (AIM: TED), a rapidly growing molecular ...
... of Matthew L. MyersPresident, Campaign for Tobacco-Free KidsWASHINGTON, Jan. ... a tremendous victory for children,s health by voting to ... the cigarette tax, to fund reauthorization and expansion of ... This legislation will create a healthier future for millions ...
... Research presented today at the American,Academy of ... correlation,between ,catastrophizing, about pain during the experience of ... parts of the central,nervous system that mediate pain ... this link. Previous studies have looked at ...
... at the American,Academy of Pain Medicine,s 25th Annual Meeting ... public perceptions about their,safety and patient non-compliance in the ... studies at this year,s meeting illuminate the issues faced ... treatments. Two studies,highlight some of the most important ...
... of disease worked, study finds , , THURSDAY, Jan. 29 (HealthDay ... some cases, undo neurological damage in people with multiple sclerosis, ... 21 patients, but a larger, randomized trial is under way ... the first trial for any phase of MS, whether early ...
Cached Medicine News:Health News:Applications for Social Security Disability Reach 2.6 Million 2Health News:Applications for Social Security Disability Reach 2.6 Million 3Health News:Applications for Social Security Disability Reach 2.6 Million 4Health News:Applications for Social Security Disability Reach 2.6 Million 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 2Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 3Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 4Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 6Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 7Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 8Health News:U.S. Senate Acts to Protect Kids, Save Lives by Increasing Federal Tobacco Taxes 2Health News:Negative Emotions About Pain Increase Pro-Inflammatory Response 2Health News:Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety 2Health News:Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety 3Health News:Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety 4Health News:Stem Cell Transplants Help MS Victims 2Health News:Stem Cell Transplants Help MS Victims 3
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... The HAAG-STREIT OM 900 Ophthalmometer uses ... the three requirements of Helmholtz: 1. The ... of the distance between the Ophthalmometer and ... are independent of the distance between the ...
Medicine Products: